A Painful HIT

Chakraverty R Davidson S Peggs K Stross P Garrard C Littlewood TJ . The incidence and cause of coagulopathies in an intensive care population. Br J Haemotol. 1996;93(2):460–463.

Stephan F Hollande J Richard O Cheffi A Maier-Redelsperger M Flahault A . Thrombocytopenia in a surgical ICU. Chest. 1999;115(5):1363–1370.

Handin R Disordered of the platelet and vessel wall. In: Braunwald E Fauci A Kasper D Hauser S Longo D Jameson LJ (Eds.), Harrison’s Principles of Internal Medicine. 15th ed. 2001;New York, NY: McGraw-Hill, 745–750.

Chong BH Castaldi PA . Platelet proaggregating effect of heparin: possible mechanism for non-immune heparin-associated thrombocytopenia. Aust N Z J Med. 1986;16(5):715–716.

Greinacher A . Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost. 1995;21(1):106–116.

Warkentin TE Sheppard JA Sigouin CS Kohlmann T Eichler P Greinacher A . Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood. 2006;108(9):2937–2941.

Warkentin TE Eikelboom JW . Who is (still) getting HIT? Chest. 2007;131(6):1620–1622.

Warkentin TE Kelton JG Interaction of heparin with platelets, including heparin-induced thrombocytopenia. In: Bounameaux H (Ed.), Low-Molecular Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases.1994;Fundamental and Clinical Cardiology. New York, NY: Marcel Dekker, 75.

Warkentin TE . Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol. 1998;35(4 suppl 5):9–16; discussion 35–6.

White PW Sadd JR Nensel RE . Thrombotic complications of heparin therapy: including six cases of heparin-induced skin necrosis. Ann Surg. 1979;190(5):595–608.

Arthur CK Grant SJB Murray WK Isbister JP Stiel JN Lauer CS . Heparin-associated acute adrenal insufficiency. Aust N Z J Med. 1985;15(4):454–455.

Warkentin TE Hirte HW Anderson DR Wilson WE O’Connell GJ Lo RC . Transient global amnesia associated with acute heparin-induced thrombocytopenia. Am J Med. 1994;97(5):489–491.

Visentin GP Ford SE Scott JP Aster RH . Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest. 1994;93(1):81–88.

Rauova L Zhai L Kowalska MA Arepally GM Cines DB Poncz M . Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood. 2006;107(6):2346–2353.

Kelton JG Smith JW Warkentin TE Hayward CP Denomme GA Horsewood P . Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood. 1994;83(11):3232–3239.

Rauova L Poncz M McKenzie SE . Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia. Blood. 2005;105(1):131–138.

Greinacher A Potzsch B Amiral J Dummel V Eichner A Mueller-Eckhardt C . Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen [see comments]. Thromb Haemost. 1994;71(2):247–251.

Newman PM Chong BH . Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood. 2000;96(1):182–187.

Stanton PE Jr Evans JR Lefemine AA . White clot syndrome. South Med J. 1988;81(5):616–620.

Hughes M Hayward CP Warkentin TE Horsewood P Chorneyko KA Kelton JG . Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood. 2000;96(1):188–194.

Blank M Shoenfeld Y Tavor S . Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol. 2002;14(2):121–129.

Stribling WK Slaughter TF Houle TT . Beyond the platelet count: heparin antibodies as independent risk predictors. Am Heart J. 2007;153(6):900–906.

Lo GK Juhl D Warkentin TE Sigouin CS Eichler P Greinacher A . Evaluation of pretest clinical score (4T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–765.

Martinuzzo ME Forastiero RR Adamczuk Y Pombo G Carreras LO . Antiplatelet factor 4—heparin antibodies in patients with antiphospholipid antibodies. Thromb Res. 1999;95(6):271–279.

de Larranaga G Martinuzzo M Bocassi A Fressart MM Forastiero R . Heparin-platelet factor 4 induced antibodies in patients with either autoimmune or alloimmune antiphospholipid antibodies. Thromb Haemost. 2002;88(2):371–373.

Arepally GM Ortel TL . Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2006;355(8):809–817.

Pouplard C Amiral J Borg JY Laporte-Simitsidis S Delahousse B Gruel Y . Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol. 1999;111(5):700–706.

Schenk S El-Banayosy A Morshuis M . IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support. J Thromb Haemost. 2007;5(2):235–241.

Chong BH Burgess J Ismail F . The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost. 1993;69(4):344–350.

Greinacher A Amiral J Dummel V Vissac A Kiefel V Mueller-Eckhardt C . Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion. 1994;34(5):381–385.

Warkentin TE Levine MN Hirsh J . Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332(20):1330–1335.

Napolitano LM Warkentin TE Almahameed A Nasraway SA . Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management. Crit Care Med. 2006;34(12):2898–2911.

Sheridan D Carter C Kelton JG . A diagnostic test for heparin-induced thrombocytopenia. Blood. 1986;67(1):27–30.

Warkentin TE . Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia. Arch Pathol Lab Med. 2002;126(11):1415–1423.

Warkentin TE Greinacher A Koster A . Bivalirudin. Thromb Haemost. 2008;99(5):830–839.

Koster A Dyke CM Aldea G . Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Ann Thor Surg. 2007;83(2):572–577.

Koster A Buz S Krabatsch T . Effect of modified ultrafiltration on bivalirudin elimination and postoperative blood loss after on-pump coronary artery bypass grafting: assessment of different filtration strategies. J Card Surg. 2008;23(6):655–658.

Pötzsch B Klovekorn WP Madlener K . Use of heparin during cardiopulmonary bypass in patients with a history of heparin induced thrombocytopenia. N Engl J Med. 2000;343(7):515.

Warkentin TE Greinacher A Koster A Lincoff AM ; American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest. 2008;133(6 suppl):340S–380S.

Warkentin TE Greinacher A Koster A . Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required? Ann Thorac Surg. 2009;87(5):1633–1640.